COVID-19 Impact on Global Precision Cancer Tests Market Size, Status and Forecast 2020-2026
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Cancer Tests market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Precision Cancer Tests industry.
Based on our recent survey, we have several different scenarios about the Precision Cancer Tests YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Precision Cancer Tests will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Tests market in terms of revenue.
Players, stakeholders, and other participants in the global Precision Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Precision Cancer Tests market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Precision Cancer Tests market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Tests market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Cancer Tests market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Precision Cancer Tests industry.
Based on our recent survey, we have several different scenarios about the Precision Cancer Tests YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Precision Cancer Tests will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Tests market in terms of revenue.
Players, stakeholders, and other participants in the global Precision Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Precision Cancer Tests market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Precision Cancer Tests market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Tests market.
The following players are covered in this report:
- Abbott
- BD
- Bio-Rad
- Cynvenio Biosystems
- Foundation Medicine
- Genomic Health
- Illumina
- Myriad Genetics
- NanoString Technologies
- QIAGEN
- Randox Laboratories
- Roche
- Philips
- Thermo Fisher Scientific
- Imaging
- In Vitro Diagnostic
- Others
- Cancer Research Centers
- Cancer Hospital
- Surgical Centers
- Clinics
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Precision Cancer Tests Revenue
1.4 Market Analysis by Type
1.4.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Imaging
1.4.3 In Vitro Diagnostic
1.4.4 Others
1.5 Market by Application
1.5.1 Global Precision Cancer Tests Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Cancer Hospital
1.5.4 Surgical Centers
1.5.5 Clinics
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Precision Cancer Tests Industry Impact
1.6.1 How the Covid-19 is Affecting the Precision Cancer Tests Industry
1.6.1.1 Precision Cancer Tests Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Precision Cancer Tests Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Precision Cancer Tests Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Precision Cancer Tests Market Perspective (2015-2026)
2.2 Precision Cancer Tests Growth Trends by Regions
2.2.1 Precision Cancer Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Precision Cancer Tests Historic Market Share by Regions (2015-2020)
2.2.3 Precision Cancer Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Precision Cancer Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Precision Cancer Tests Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Precision Cancer Tests Players by Market Size
3.1.1 Global Top Precision Cancer Tests Players by Revenue (2015-2020)
3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Precision Cancer Tests Market Concentration Ratio
3.2.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2019
3.3 Precision Cancer Tests Key Players Head office and Area Served
3.4 Key Players Precision Cancer Tests Product Solution and Service
3.5 Date of Enter into Precision Cancer Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Precision Cancer Tests Historic Market Size by Type (2015-2020)
4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2021-2026)
5 PRECISION CANCER TESTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Precision Cancer Tests Market Size by Application (2015-2020)
5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Precision Cancer Tests Market Size (2015-2020)
6.2 Precision Cancer Tests Key Players in North America (2019-2020)
6.3 North America Precision Cancer Tests Market Size by Type (2015-2020)
6.4 North America Precision Cancer Tests Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Precision Cancer Tests Market Size (2015-2020)
7.2 Precision Cancer Tests Key Players in Europe (2019-2020)
7.3 Europe Precision Cancer Tests Market Size by Type (2015-2020)
7.4 Europe Precision Cancer Tests Market Size by Application (2015-2020)
8 CHINA
8.1 China Precision Cancer Tests Market Size (2015-2020)
8.2 Precision Cancer Tests Key Players in China (2019-2020)
8.3 China Precision Cancer Tests Market Size by Type (2015-2020)
8.4 China Precision Cancer Tests Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Precision Cancer Tests Market Size (2015-2020)
9.2 Precision Cancer Tests Key Players in Japan (2019-2020)
9.3 Japan Precision Cancer Tests Market Size by Type (2015-2020)
9.4 Japan Precision Cancer Tests Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Precision Cancer Tests Market Size (2015-2020)
10.2 Precision Cancer Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Precision Cancer Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Precision Cancer Tests Market Size by Application (2015-2020)
11 INDIA
11.1 India Precision Cancer Tests Market Size (2015-2020)
11.2 Precision Cancer Tests Key Players in India (2019-2020)
11.3 India Precision Cancer Tests Market Size by Type (2015-2020)
11.4 India Precision Cancer Tests Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Precision Cancer Tests Market Size (2015-2020)
12.2 Precision Cancer Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Precision Cancer Tests Market Size by Type (2015-2020)
12.4 Central & South America Precision Cancer Tests Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Precision Cancer Tests Introduction
13.1.4 Abbott Revenue in Precision Cancer Tests Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 BD
13.2.1 BD Company Details
13.2.2 BD Business Overview and Its Total Revenue
13.2.3 BD Precision Cancer Tests Introduction
13.2.4 BD Revenue in Precision Cancer Tests Business (2015-2020)
13.2.5 BD Recent Development
13.3 Bio-Rad
13.3.1 Bio-Rad Company Details
13.3.2 Bio-Rad Business Overview and Its Total Revenue
13.3.3 Bio-Rad Precision Cancer Tests Introduction
13.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2015-2020)
13.3.5 Bio-Rad Recent Development
13.4 Cynvenio Biosystems
13.4.1 Cynvenio Biosystems Company Details
13.4.2 Cynvenio Biosystems Business Overview and Its Total Revenue
13.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
13.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2015-2020)
13.4.5 Cynvenio Biosystems Recent Development
13.5 Foundation Medicine
13.5.1 Foundation Medicine Company Details
13.5.2 Foundation Medicine Business Overview and Its Total Revenue
13.5.3 Foundation Medicine Precision Cancer Tests Introduction
13.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2015-2020)
13.5.5 Foundation Medicine Recent Development
13.6 Genomic Health
13.6.1 Genomic Health Company Details
13.6.2 Genomic Health Business Overview and Its Total Revenue
13.6.3 Genomic Health Precision Cancer Tests Introduction
13.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2015-2020)
13.6.5 Genomic Health Recent Development
13.7 Illumina
13.7.1 Illumina Company Details
13.7.2 Illumina Business Overview and Its Total Revenue
13.7.3 Illumina Precision Cancer Tests Introduction
13.7.4 Illumina Revenue in Precision Cancer Tests Business (2015-2020)
13.7.5 Illumina Recent Development
13.8 Myriad Genetics
13.8.1 Myriad Genetics Company Details
13.8.2 Myriad Genetics Business Overview and Its Total Revenue
13.8.3 Myriad Genetics Precision Cancer Tests Introduction
13.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2015-2020)
13.8.5 Myriad Genetics Recent Development
13.9 NanoString Technologies
13.9.1 NanoString Technologies Company Details
13.9.2 NanoString Technologies Business Overview and Its Total Revenue
13.9.3 NanoString Technologies Precision Cancer Tests Introduction
13.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2015-2020)
13.9.5 NanoString Technologies Recent Development
13.10 QIAGEN
13.10.1 QIAGEN Company Details
13.10.2 QIAGEN Business Overview and Its Total Revenue
13.10.3 QIAGEN Precision Cancer Tests Introduction
13.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2015-2020)
13.10.5 QIAGEN Recent Development
13.11 Randox Laboratories
10.11.1 Randox Laboratories Company Details
10.11.2 Randox Laboratories Business Overview and Its Total Revenue
10.11.3 Randox Laboratories Precision Cancer Tests Introduction
10.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2015-2020)
10.11.5 Randox Laboratories Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview and Its Total Revenue
10.12.3 Roche Precision Cancer Tests Introduction
10.12.4 Roche Revenue in Precision Cancer Tests Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Philips
10.13.1 Philips Company Details
10.13.2 Philips Business Overview and Its Total Revenue
10.13.3 Philips Precision Cancer Tests Introduction
10.13.4 Philips Revenue in Precision Cancer Tests Business (2015-2020)
10.13.5 Philips Recent Development
13.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Details
10.14.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
10.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2015-2020)
10.14.5 Thermo Fisher Scientific Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Precision Cancer Tests Revenue
1.4 Market Analysis by Type
1.4.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Imaging
1.4.3 In Vitro Diagnostic
1.4.4 Others
1.5 Market by Application
1.5.1 Global Precision Cancer Tests Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Cancer Hospital
1.5.4 Surgical Centers
1.5.5 Clinics
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Precision Cancer Tests Industry Impact
1.6.1 How the Covid-19 is Affecting the Precision Cancer Tests Industry
1.6.1.1 Precision Cancer Tests Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Precision Cancer Tests Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Precision Cancer Tests Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Precision Cancer Tests Market Perspective (2015-2026)
2.2 Precision Cancer Tests Growth Trends by Regions
2.2.1 Precision Cancer Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Precision Cancer Tests Historic Market Share by Regions (2015-2020)
2.2.3 Precision Cancer Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Precision Cancer Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Precision Cancer Tests Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Precision Cancer Tests Players by Market Size
3.1.1 Global Top Precision Cancer Tests Players by Revenue (2015-2020)
3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Precision Cancer Tests Market Concentration Ratio
3.2.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2019
3.3 Precision Cancer Tests Key Players Head office and Area Served
3.4 Key Players Precision Cancer Tests Product Solution and Service
3.5 Date of Enter into Precision Cancer Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Precision Cancer Tests Historic Market Size by Type (2015-2020)
4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2021-2026)
5 PRECISION CANCER TESTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Precision Cancer Tests Market Size by Application (2015-2020)
5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Precision Cancer Tests Market Size (2015-2020)
6.2 Precision Cancer Tests Key Players in North America (2019-2020)
6.3 North America Precision Cancer Tests Market Size by Type (2015-2020)
6.4 North America Precision Cancer Tests Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Precision Cancer Tests Market Size (2015-2020)
7.2 Precision Cancer Tests Key Players in Europe (2019-2020)
7.3 Europe Precision Cancer Tests Market Size by Type (2015-2020)
7.4 Europe Precision Cancer Tests Market Size by Application (2015-2020)
8 CHINA
8.1 China Precision Cancer Tests Market Size (2015-2020)
8.2 Precision Cancer Tests Key Players in China (2019-2020)
8.3 China Precision Cancer Tests Market Size by Type (2015-2020)
8.4 China Precision Cancer Tests Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Precision Cancer Tests Market Size (2015-2020)
9.2 Precision Cancer Tests Key Players in Japan (2019-2020)
9.3 Japan Precision Cancer Tests Market Size by Type (2015-2020)
9.4 Japan Precision Cancer Tests Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Precision Cancer Tests Market Size (2015-2020)
10.2 Precision Cancer Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Precision Cancer Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Precision Cancer Tests Market Size by Application (2015-2020)
11 INDIA
11.1 India Precision Cancer Tests Market Size (2015-2020)
11.2 Precision Cancer Tests Key Players in India (2019-2020)
11.3 India Precision Cancer Tests Market Size by Type (2015-2020)
11.4 India Precision Cancer Tests Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Precision Cancer Tests Market Size (2015-2020)
12.2 Precision Cancer Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Precision Cancer Tests Market Size by Type (2015-2020)
12.4 Central & South America Precision Cancer Tests Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Precision Cancer Tests Introduction
13.1.4 Abbott Revenue in Precision Cancer Tests Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 BD
13.2.1 BD Company Details
13.2.2 BD Business Overview and Its Total Revenue
13.2.3 BD Precision Cancer Tests Introduction
13.2.4 BD Revenue in Precision Cancer Tests Business (2015-2020)
13.2.5 BD Recent Development
13.3 Bio-Rad
13.3.1 Bio-Rad Company Details
13.3.2 Bio-Rad Business Overview and Its Total Revenue
13.3.3 Bio-Rad Precision Cancer Tests Introduction
13.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2015-2020)
13.3.5 Bio-Rad Recent Development
13.4 Cynvenio Biosystems
13.4.1 Cynvenio Biosystems Company Details
13.4.2 Cynvenio Biosystems Business Overview and Its Total Revenue
13.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
13.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2015-2020)
13.4.5 Cynvenio Biosystems Recent Development
13.5 Foundation Medicine
13.5.1 Foundation Medicine Company Details
13.5.2 Foundation Medicine Business Overview and Its Total Revenue
13.5.3 Foundation Medicine Precision Cancer Tests Introduction
13.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2015-2020)
13.5.5 Foundation Medicine Recent Development
13.6 Genomic Health
13.6.1 Genomic Health Company Details
13.6.2 Genomic Health Business Overview and Its Total Revenue
13.6.3 Genomic Health Precision Cancer Tests Introduction
13.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2015-2020)
13.6.5 Genomic Health Recent Development
13.7 Illumina
13.7.1 Illumina Company Details
13.7.2 Illumina Business Overview and Its Total Revenue
13.7.3 Illumina Precision Cancer Tests Introduction
13.7.4 Illumina Revenue in Precision Cancer Tests Business (2015-2020)
13.7.5 Illumina Recent Development
13.8 Myriad Genetics
13.8.1 Myriad Genetics Company Details
13.8.2 Myriad Genetics Business Overview and Its Total Revenue
13.8.3 Myriad Genetics Precision Cancer Tests Introduction
13.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2015-2020)
13.8.5 Myriad Genetics Recent Development
13.9 NanoString Technologies
13.9.1 NanoString Technologies Company Details
13.9.2 NanoString Technologies Business Overview and Its Total Revenue
13.9.3 NanoString Technologies Precision Cancer Tests Introduction
13.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2015-2020)
13.9.5 NanoString Technologies Recent Development
13.10 QIAGEN
13.10.1 QIAGEN Company Details
13.10.2 QIAGEN Business Overview and Its Total Revenue
13.10.3 QIAGEN Precision Cancer Tests Introduction
13.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2015-2020)
13.10.5 QIAGEN Recent Development
13.11 Randox Laboratories
10.11.1 Randox Laboratories Company Details
10.11.2 Randox Laboratories Business Overview and Its Total Revenue
10.11.3 Randox Laboratories Precision Cancer Tests Introduction
10.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2015-2020)
10.11.5 Randox Laboratories Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview and Its Total Revenue
10.12.3 Roche Precision Cancer Tests Introduction
10.12.4 Roche Revenue in Precision Cancer Tests Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Philips
10.13.1 Philips Company Details
10.13.2 Philips Business Overview and Its Total Revenue
10.13.3 Philips Precision Cancer Tests Introduction
10.13.4 Philips Revenue in Precision Cancer Tests Business (2015-2020)
10.13.5 Philips Recent Development
13.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Details
10.14.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
10.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2015-2020)
10.14.5 Thermo Fisher Scientific Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Precision Cancer Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Precision Cancer Tests Revenue
Table 3. Ranking of Global Top Precision Cancer Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging
Table 6. Key Players of In Vitro Diagnostic
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Precision Cancer Tests Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Precision Cancer Tests Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Precision Cancer Tests Players to Combat Covid-19 Impact
Table 13. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Precision Cancer Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Precision Cancer Tests Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Precision Cancer Tests Market Share by Regions (2015-2020)
Table 17. Global Precision Cancer Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Precision Cancer Tests Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Precision Cancer Tests Market Growth Strategy
Table 23. Main Points Interviewed from Key Precision Cancer Tests Players
Table 24. Global Precision Cancer Tests Revenue by Players (2015-2020) (Million US$)
Table 25. Global Precision Cancer Tests Market Share by Players (2015-2020)
Table 26. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2019)
Table 27. Global Precision Cancer Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Precision Cancer Tests Product Solution and Service
Table 30. Date of Enter into Precision Cancer Tests Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 33. Global Precision Cancer Tests Market Size Share by Type (2015-2020)
Table 34. Global Precision Cancer Tests Revenue Market Share by Type (2021-2026)
Table 35. Global Precision Cancer Tests Market Size Share by Application (2015-2020)
Table 36. Global Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 37. Global Precision Cancer Tests Market Size Share by Application (2021-2026)
Table 38. North America Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Precision Cancer Tests Market Share (2019-2020)
Table 40. North America Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 41. North America Precision Cancer Tests Market Share by Type (2015-2020)
Table 42. North America Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 43. North America Precision Cancer Tests Market Share by Application (2015-2020)
Table 44. Europe Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Precision Cancer Tests Market Share (2019-2020)
Table 46. Europe Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Precision Cancer Tests Market Share by Type (2015-2020)
Table 48. Europe Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Precision Cancer Tests Market Share by Application (2015-2020)
Table 50. China Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 51. China Key Players Precision Cancer Tests Market Share (2019-2020)
Table 52. China Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 53. China Precision Cancer Tests Market Share by Type (2015-2020)
Table 54. China Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 55. China Precision Cancer Tests Market Share by Application (2015-2020)
Table 56. Japan Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Precision Cancer Tests Market Share (2019-2020)
Table 58. Japan Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Precision Cancer Tests Market Share by Type (2015-2020)
Table 60. Japan Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Precision Cancer Tests Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Precision Cancer Tests Market Share (2019-2020)
Table 64. Southeast Asia Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Precision Cancer Tests Market Share by Type (2015-2020)
Table 66. Southeast Asia Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Precision Cancer Tests Market Share by Application (2015-2020)
Table 68. India Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 69. India Key Players Precision Cancer Tests Market Share (2019-2020)
Table 70. India Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 71. India Precision Cancer Tests Market Share by Type (2015-2020)
Table 72. India Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 73. India Precision Cancer Tests Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Precision Cancer Tests Market Share (2019-2020)
Table 76. Central & South America Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Precision Cancer Tests Market Share by Type (2015-2020)
Table 78. Central & South America Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Precision Cancer Tests Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. BD Company Details
Table 86. BD Business Overview
Table 87. BD Product
Table 88. BD Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 89. BD Recent Development
Table 90. Bio-Rad Company Details
Table 91. Bio-Rad Business Overview
Table 92. Bio-Rad Product
Table 93. Bio-Rad Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 94. Bio-Rad Recent Development
Table 95. Cynvenio Biosystems Company Details
Table 96. Cynvenio Biosystems Business Overview
Table 97. Cynvenio Biosystems Product
Table 98. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 99. Cynvenio Biosystems Recent Development
Table 100. Foundation Medicine Company Details
Table 101. Foundation Medicine Business Overview
Table 102. Foundation Medicine Product
Table 103. Foundation Medicine Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 104. Foundation Medicine Recent Development
Table 105. Genomic Health Company Details
Table 106. Genomic Health Business Overview
Table 107. Genomic Health Product
Table 108. Genomic Health Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 109. Genomic Health Recent Development
Table 110. Illumina Company Details
Table 111. Illumina Business Overview
Table 112. Illumina Product
Table 113. Illumina Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 114. Illumina Recent Development
Table 115. Myriad Genetics Business Overview
Table 116. Myriad Genetics Product
Table 117. Myriad Genetics Company Details
Table 118. Myriad Genetics Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 119. Myriad Genetics Recent Development
Table 120. NanoString Technologies Company Details
Table 121. NanoString Technologies Business Overview
Table 122. NanoString Technologies Product
Table 123. NanoString Technologies Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 124. NanoString Technologies Recent Development
Table 125. QIAGEN Company Details
Table 126. QIAGEN Business Overview
Table 127. QIAGEN Product
Table 128. QIAGEN Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 129. QIAGEN Recent Development
Table 130. Randox Laboratories Company Details
Table 131. Randox Laboratories Business Overview
Table 132. Randox Laboratories Product
Table 133. Randox Laboratories Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 134. Randox Laboratories Recent Development
Table 135. Roche Company Details
Table 136. Roche Business Overview
Table 137. Roche Product
Table 138. Roche Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 139. Roche Recent Development
Table 140. Philips Company Details
Table 141. Philips Business Overview
Table 142. Philips Product
Table 143. Philips Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 144. Philips Recent Development
Table 145. Thermo Fisher Scientific Company Details
Table 146. Thermo Fisher Scientific Business Overview
Table 147. Thermo Fisher Scientific Product
Table 148. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 149. Thermo Fisher Scientific Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 1. Precision Cancer Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Precision Cancer Tests Revenue
Table 3. Ranking of Global Top Precision Cancer Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging
Table 6. Key Players of In Vitro Diagnostic
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Precision Cancer Tests Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Precision Cancer Tests Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Precision Cancer Tests Players to Combat Covid-19 Impact
Table 13. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Precision Cancer Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Precision Cancer Tests Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Precision Cancer Tests Market Share by Regions (2015-2020)
Table 17. Global Precision Cancer Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Precision Cancer Tests Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Precision Cancer Tests Market Growth Strategy
Table 23. Main Points Interviewed from Key Precision Cancer Tests Players
Table 24. Global Precision Cancer Tests Revenue by Players (2015-2020) (Million US$)
Table 25. Global Precision Cancer Tests Market Share by Players (2015-2020)
Table 26. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2019)
Table 27. Global Precision Cancer Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Precision Cancer Tests Product Solution and Service
Table 30. Date of Enter into Precision Cancer Tests Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 33. Global Precision Cancer Tests Market Size Share by Type (2015-2020)
Table 34. Global Precision Cancer Tests Revenue Market Share by Type (2021-2026)
Table 35. Global Precision Cancer Tests Market Size Share by Application (2015-2020)
Table 36. Global Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 37. Global Precision Cancer Tests Market Size Share by Application (2021-2026)
Table 38. North America Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Precision Cancer Tests Market Share (2019-2020)
Table 40. North America Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 41. North America Precision Cancer Tests Market Share by Type (2015-2020)
Table 42. North America Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 43. North America Precision Cancer Tests Market Share by Application (2015-2020)
Table 44. Europe Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Precision Cancer Tests Market Share (2019-2020)
Table 46. Europe Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Precision Cancer Tests Market Share by Type (2015-2020)
Table 48. Europe Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Precision Cancer Tests Market Share by Application (2015-2020)
Table 50. China Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 51. China Key Players Precision Cancer Tests Market Share (2019-2020)
Table 52. China Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 53. China Precision Cancer Tests Market Share by Type (2015-2020)
Table 54. China Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 55. China Precision Cancer Tests Market Share by Application (2015-2020)
Table 56. Japan Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Precision Cancer Tests Market Share (2019-2020)
Table 58. Japan Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Precision Cancer Tests Market Share by Type (2015-2020)
Table 60. Japan Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Precision Cancer Tests Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Precision Cancer Tests Market Share (2019-2020)
Table 64. Southeast Asia Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Precision Cancer Tests Market Share by Type (2015-2020)
Table 66. Southeast Asia Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Precision Cancer Tests Market Share by Application (2015-2020)
Table 68. India Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 69. India Key Players Precision Cancer Tests Market Share (2019-2020)
Table 70. India Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 71. India Precision Cancer Tests Market Share by Type (2015-2020)
Table 72. India Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 73. India Precision Cancer Tests Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Precision Cancer Tests Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Precision Cancer Tests Market Share (2019-2020)
Table 76. Central & South America Precision Cancer Tests Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Precision Cancer Tests Market Share by Type (2015-2020)
Table 78. Central & South America Precision Cancer Tests Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Precision Cancer Tests Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. BD Company Details
Table 86. BD Business Overview
Table 87. BD Product
Table 88. BD Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 89. BD Recent Development
Table 90. Bio-Rad Company Details
Table 91. Bio-Rad Business Overview
Table 92. Bio-Rad Product
Table 93. Bio-Rad Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 94. Bio-Rad Recent Development
Table 95. Cynvenio Biosystems Company Details
Table 96. Cynvenio Biosystems Business Overview
Table 97. Cynvenio Biosystems Product
Table 98. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 99. Cynvenio Biosystems Recent Development
Table 100. Foundation Medicine Company Details
Table 101. Foundation Medicine Business Overview
Table 102. Foundation Medicine Product
Table 103. Foundation Medicine Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 104. Foundation Medicine Recent Development
Table 105. Genomic Health Company Details
Table 106. Genomic Health Business Overview
Table 107. Genomic Health Product
Table 108. Genomic Health Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 109. Genomic Health Recent Development
Table 110. Illumina Company Details
Table 111. Illumina Business Overview
Table 112. Illumina Product
Table 113. Illumina Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 114. Illumina Recent Development
Table 115. Myriad Genetics Business Overview
Table 116. Myriad Genetics Product
Table 117. Myriad Genetics Company Details
Table 118. Myriad Genetics Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 119. Myriad Genetics Recent Development
Table 120. NanoString Technologies Company Details
Table 121. NanoString Technologies Business Overview
Table 122. NanoString Technologies Product
Table 123. NanoString Technologies Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 124. NanoString Technologies Recent Development
Table 125. QIAGEN Company Details
Table 126. QIAGEN Business Overview
Table 127. QIAGEN Product
Table 128. QIAGEN Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 129. QIAGEN Recent Development
Table 130. Randox Laboratories Company Details
Table 131. Randox Laboratories Business Overview
Table 132. Randox Laboratories Product
Table 133. Randox Laboratories Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 134. Randox Laboratories Recent Development
Table 135. Roche Company Details
Table 136. Roche Business Overview
Table 137. Roche Product
Table 138. Roche Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 139. Roche Recent Development
Table 140. Philips Company Details
Table 141. Philips Business Overview
Table 142. Philips Product
Table 143. Philips Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 144. Philips Recent Development
Table 145. Thermo Fisher Scientific Company Details
Table 146. Thermo Fisher Scientific Business Overview
Table 147. Thermo Fisher Scientific Product
Table 148. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2015-2020) (Million US$)
Table 149. Thermo Fisher Scientific Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Precision Cancer Tests Market Share by Type: 2020 VS 2026
Figure 2. Imaging Features
Figure 3. In Vitro Diagnostic Features
Figure 4. Others Features
Figure 5. Global Precision Cancer Tests Market Share by Application: 2020 VS 2026
Figure 6. Cancer Research Centers Case Studies
Figure 7. Cancer Hospital Case Studies
Figure 8. Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Precision Cancer Tests Report Years Considered
Figure 12. Global Precision Cancer Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Precision Cancer Tests Market Share by Regions: 2020 VS 2026
Figure 14. Global Precision Cancer Tests Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Precision Cancer Tests Market Share by Players in 2019
Figure 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2019
Figure 19. North America Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 28. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. BD Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 30. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 32. Cynvenio Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 34. Foundation Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 36. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 38. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 40. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 42. NanoString Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 44. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 46. Randox Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 48. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Roche Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 50. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Philips Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 52. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Figure 1. Global Precision Cancer Tests Market Share by Type: 2020 VS 2026
Figure 2. Imaging Features
Figure 3. In Vitro Diagnostic Features
Figure 4. Others Features
Figure 5. Global Precision Cancer Tests Market Share by Application: 2020 VS 2026
Figure 6. Cancer Research Centers Case Studies
Figure 7. Cancer Hospital Case Studies
Figure 8. Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Precision Cancer Tests Report Years Considered
Figure 12. Global Precision Cancer Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Precision Cancer Tests Market Share by Regions: 2020 VS 2026
Figure 14. Global Precision Cancer Tests Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Precision Cancer Tests Market Share by Players in 2019
Figure 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2019
Figure 19. North America Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Precision Cancer Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 28. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. BD Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 30. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 32. Cynvenio Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 34. Foundation Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 36. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 38. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 40. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 42. NanoString Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 44. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 46. Randox Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 48. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Roche Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 50. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Philips Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 52. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
